Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
University Of Pittsburgh Of The Commonwealth System Of Higher Education has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, HADDAD, MAHER M, in 1 distinct art unit. As the busiest examiner with 1 pending action, HADDAD, MAHER M is the only examiner currently overseeing the active prosecution. This single-action docket requires a targeted response to the specific examiner's findings.
Practitioners should analyze the 1 pending office action in the context of HADDAD, MAHER M's past decisions to develop an effective strategy for the 1 distinct art unit. The concentration of the university's current patent efforts in this one matter means that all resources can be directed toward a single set of examiner concerns in the Biotechnology & Pharmaceuticals sector. Navigating the 1 distinct art unit's standards will be essential for moving this 1 pending office action toward a successful allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HADDAD, MAHER M | 1 | 50.6% | +53.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18700535 | MOLECULES THAT BIND TO CD276 POLYPEPTIDES | HADDAD, MAHER M | — |
| Art Unit | Apps |
|---|---|
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18700535 | MOLECULES THAT BIND TO CD276 POLYPEPTIDES | HADDAD, MAHER M | 1641 | §112 | Non-Final OA | — | Pending | Apr 11, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity Of Pittsburgh Of The Commonwealth System Of Higher Education has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Maher M Haddad has the most, with 1 of University Of Pittsburgh Of The Commonwealth System Of Higher Education's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
